Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Directing systemic oncolytic viral delivery to tumors via carrier cells.
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.
Switching a replication-defective adenoviral vector into a replication-competent, oncolytic adenovirus.
Modification of HSV-1 to an oncolytic virus.
HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy.
Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma.
Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy.
Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma.
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.
Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses.
Redesigned reporter gene for improved proton exchange-based molecular MRI contrast.
Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells.